Dandex

Novo Nordisk North America Operations A/S

CVR 33761201Public limited company (A/S)Anden finansiel formidling i.a.n. (649990)BagsværdFounded 14 Jun 2011

Gross profit

-59K

DKK, annual report 2025

Result

-74,1M

DKK, annual report 2025

Equity

60M

DKK, annual report 2025

Who Is Behind It

Owner

NOVO NORDISK A/SCVR 24256790, 100% of capital and votes, since 14 Jun 2011

Ultimate controller
NOVO NORDISK FONDENCVR 10582989, through NOVO NORDISK A/S, a Dandex estimate
Director

Anders Rytter Mikkelsensince 12 May 2026

Ownership

Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.

Control Chain

  1. Ultimate controller

    NOVO NORDISK FONDEN

    CVR 10582989Commercial foundation (Erhvervsdrivende fond)

    Holds 100% of capital and votes in Novo Holdings A/S, since 16 Oct 1999

    Capital100%
    Votes100%
  2. Holding company

    Novo Holdings A/S

    CVR 24257630Public limited company (A/S)

    Holds 25% to under 33,3% of capital and 66,7% to under 90% of votes in NOVO NORDISK A/S, since 13 Nov 2000

    Capital25% to under 33,3%
    Votes66,7% to under 90%
  3. Holding company

    NOVO NORDISK A/S

    CVR 24256790Public limited company (A/S)

    Holds 100% of capital and votes in Novo Nordisk North America Operations A/S, since 14 Jun 2011

    Capital100%
    Votes100%
  4. This company

    Novo Nordisk North America Operations A/S

    CVR 33761201

Each holds the one below it. Control follows votes: an owner with 50% or more controls. Each bar shows the registered band, solid to its lower bound and faint across the range CVR records, with a mark at 50%. Dandex estimate, computed 19 Oct 2026.

People

Current (4)

Founders (1)

CVR records founders at incorporation. It does not record whether they are alive or still involved.

Former (11)

Network

Roles Over Time

15 Dec 2020 to 19 Oct 2026.

Former (11)

14 Jun 2011 to 19 Oct 2026.

Executive board (Direktion)Board of directors (Bestyrelse)Each bar is one role, from its start to its end or today. Bars in a group share one scale. Source: CVR.

Financials

Annual report figures by year, DKK thousands
Metric20212022202320242025
Revenue188.93131.2960Not reportedNot reported
Gross profitNot reported448.029-365-119-59
Operating profit-422.171+448.029Not reportedNot reportedNot reported
Result for the year-467.036+334.269+1.092.811-89.167-74.142
Equity7.810.442639.1621.134.501438.25260.045
Total assets9.624.0721.040.8981.774.8561.329.5191.158.586
Employees (average)Not reportedNot reportedNot reportedNot reported0

DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.

Annual Reports

  • Annual report 2025

    1 Jan 2025 to 31 Dec 2025, published 8 Jun 2026

  • Annual report 2024

    1 Jan 2024 to 31 Dec 2024, published 3 Jun 2025

  • Annual report 2023

    1 Jan 2023 to 31 Dec 2023, published 4 Jun 2024

  • Annual report 2022

    1 Jan 2022 to 31 Dec 2022, published 25 May 2023

  • Annual report 2021

    1 Jan 2021 to 31 Dec 2021, published 20 May 2022

  1. Novo Nordisk North America Operations A/S has new leadership, a good time to reach out.

    Signal, a Dandex estimate. Lapses 16 Jan 2027.

Registration

Address
Novo Alle 1
2880 Bagsværd
Gladsaxe Municipality
CVR record last changed
9 Oct 2026
Data read
19 Oct 2026

Production Units

1 registered in CVR.

  • Novo Nordisk North America Operations A/S

    P-number 1016932503Novo Alle 1, 2880 Bagsværd

Source: the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen. Annual reports via XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.

Ask About Novo Nordisk North America Operations A/S With AI

Connect Dandex to Claude, ChatGPT or Cursor to compare years, check credit and map the people around a company.